| Extensive impact of non-antibiotic drugs on human gut bacteria L Maier, M Pruteanu, M Kuhn, G Zeller, A Telzerow, EE Anderson, ... Nature 555 (7698), 623, 2018 | 1634 | 2018 |
| Species-specific activity of antibacterial drug combinations AR Brochado, A Telzerow, J Bobonis, M Banzhaf, A Mateus, J Selkrig, ... Nature 559, 259–263, 2018 | 309 | 2018 |
| Improved vanillin production in baker's yeast through in silico design AR Brochado, C Matos, BL Møller, J Hansen, UH Mortensen, KR Patil Microbial cell factories 9 (1), 1-15, 2010 | 299 | 2010 |
| Fe-S Cluster Biosynthesis Controls Uptake of Aminoglycosides in a ROS-Less Death Pathway B Ezraty, A Vergnes, M Banzhaf, Y Duverger, A Huguenot, AR Brochado, ... Science 340 (6140), 1583-1587, 2013 | 229 | 2013 |
| Bioaccumulation of therapeutic drugs by human gut bacteria M Klünemann, S Andrejev, S Blasche, A Mateus, P Phapale, ... Nature 597 (7877), 533-538, 2021 | 186 | 2021 |
| Proton Motive Force Disruptors Block Bacterial Competence and Horizontal Gene Transfer A Domenech, AR Brochado, V Sender, K Hentrich, B Henriques-Normark, ... Cell host & microbe, 2020 | 71 | 2020 |
| High-throughput approaches to understanding gene function and mapping network architecture in bacteria AR Brochado, A Typas Current opinion in microbiology 16 (2), 199-206, 2013 | 53 | 2013 |
| Overexpression of O‐methyltransferase leads to improved vanillin production in baker's yeast only when complemented with model‐guided network engineering AR Brochado, KR Patil Biotechnology and Bioengineering, 2012 | 52 | 2012 |
| Impact of Stoichiometry Representation on Simulation of Genotype-Phenotype Relationships in Metabolic Networks AR Brochado, S Andrejev, CD Maranas, KR Patil PLOS Computational Biology 8 (11), e1002758, 2012 | 40 | 2012 |
| The first wide‐scale drug repurposing screen using the Prestwick Chemical Library (1200 bioactive molecules) against Neisseria gonorrhoeae identifies high in vitro activity of … S Foerster, TN Gustafsson, AR Brochado, V Desilvestro, A Typas, ... Apmis 128 (3), 242-250, 2020 | 19 | 2020 |
| Systematic analysis of drug combinations against Gram-positive bacteria E Cacace, V Kim, V Varik, M Knopp, M Tietgen, A Brauer-Nikonow, ... Nature Microbiology, 1-17, 2023 | 7 | 2023 |
| The antiphage defense system CBASS controls resistance and enables killing by antifolate antibiotics in Vibrio cholerae S Brenzinger, M Airoldi, AJ Ogunleye, AR Brochado bioRxiv, 2023.02. 27.530311, 2023 | 5 | 2023 |
| Model-Guided Identification of Gene Deletion Targets for Metabolic Engineering in Saccharomyces cerevisiae AR Brochado, KR Patil Yeast Metabolic Engineering, 281-294, 2014 | 2 | 2014 |
| The Vibrio cholerae CBASS phage defence system modulates resistance and killing by antifolate antibiotics S Brenzinger, M Airoldi, AJ Ogunleye, K Jugovic, MK Amstalden, ... Nature Microbiology, 1-12, 2024 | 1 | 2024 |
| Emergence of community behaviors in the gut microbiota upon drug treatment S Garcia-Santamarina, M Kuhn, S Devendran, L Maier, M Driessen, ... bioRxiv, 2023.06. 13.544832, 2023 | 1 | 2023 |
| High-throughput profiling of drug interactions in Gram-positive bacteria E Cacace, V Kim, M Knopp, M Tietgen, A Brauer-Nikonow, K Inecik, ... bioRxiv, 2022.12. 23.521747, 2022 | 1 | 2022 |
| Investigating genotype-phenotype relationships in Saccharomyces cerevisiae metabolic network through stoichiometric modeling AR Brochado | 1 | 2012 |
| Compounds and pharmaceutical compositions for prevention and/or treatment of dysbiosis and antibacterial antidotes for microbiome-protection ARG Brochado, A Typas, L Maier, C Goemans, E Cacace US Patent App. 17/782,654, 2022 | | 2022 |
| Pharmaceutical compositions for prevention and/or/treatment of infections and antibacterial-induced dysfunctions A Typas, ARG Brochado, S Göttig US Patent App. 17/048,735, 2021 | | 2021 |
Nassos TypasGroup Leader, EMBLembl.de üzerinde doğrulanmış e-posta adresine sahip
